chr19-13286878-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4BP6_ModerateBS2
The NM_001127222.2(CACNA1A):c.3178C>T(p.Pro1060Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000479 in 1,461,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 missense
NM_001127222.2 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 3.66
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1A. . Gene score misZ: 5.7845 (greater than the threshold 3.09). Trascript score misZ: 3.9354 (greater than threshold 3.09). The gene has 137 curated pathogenic missense variants (we use a threshold of 10). The gene has 132 curated benign missense variants. GenCC has associacion of the gene with benign paroxysmal torticollis of infancy, developmental and epileptic encephalopathy, 42, undetermined early-onset epileptic encephalopathy, episodic ataxia type 2, familial or sporadic hemiplegic migraine, spinocerebellar ataxia type 6, Lennox-Gastaut syndrome, migraine, familial hemiplegic, 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.39107397).
BP6
Variant 19-13286878-G-A is Benign according to our data. Variant chr19-13286878-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 476250.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.3178C>T | p.Pro1060Ser | missense_variant | 20/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.3190C>T | p.Pro1064Ser | missense_variant | 20/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.3184C>T | p.Pro1062Ser | missense_variant | 20/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.3040C>T | p.Pro1014Ser | missense_variant | 19/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.3190C>T | p.Pro1064Ser | missense_variant | 20/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.3184C>T | p.Pro1062Ser | missense_variant | 20/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.3181C>T | p.Pro1061Ser | missense_variant | 20/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246176Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134248
GnomAD3 exomes
AF:
AC:
4
AN:
246176
Hom.:
AF XY:
AC XY:
1
AN XY:
134248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461356Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 726980
GnomAD4 exome
AF:
AC:
7
AN:
1461356
Hom.:
Cov.:
35
AF XY:
AC XY:
2
AN XY:
726980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;.;.;L;.;.;.;.;.;.;.;L;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Benign
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
MutPred
0.23
.;.;Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);.;.;Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);
MVP
MPC
0.085
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at